Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region.
Avance Clinical, will attend BIO Asia–Taiwan 2026, a premier gathering of global biotech innovators and scientific leaders.
In 2025, Harvill’s experience overseeing CROs through global expansion across Asia Pacific (APAC), Europe, and South America led him to take the helm at Avance Clinical, Australia’s leading CRO.
Avance Clinical will engage with biotech sponsors to discuss strategies for delivering efficient, high-quality oncology trials spanning first-in-human through to later-phase proof of concept global programs.
Discover how Avance Clinical’s Oncology Center of Excellence helps U.S. biotechs overcome early phase oncology challenges with expert strategy, faster startup, and global scalability.
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
Avance Clinical will attend DIA China 2026, a premier drug development life science event which brings together industry professionals from over 30 countries and regions.
Avance Clinical will attend BIO KOREA 2026, Korea’s leading international bio-health convention, connecting with biotech innovators from across Asia, North America, and Europe.
Visit us at Booth 6 to learn how we support innovative biotech companies through our Oncology Center of Excellence.
Join Avance Clinical at the Clinical Trials in Oncology West Coast 2026.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com